Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Big Rock Partners Acquisition Corp was a U.S.-based special purpose acquisition company formed to pursue a business combination, with an initial focus on senior housing and healthcare-related targets. It was not an operating biotech, pharma, or healthcare products company and did not have a therapeutic pipeline, platform technology, or drug development programs. In May 2021, the company completed its business combination with NeuroRx and changed its name to NRx Pharmaceuticals, Inc. As a result, Big Rock Partners Acquisition Corp no longer operates as an independent standalone company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Big Rock Partners Acquisition Corp.